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Granulocyte-macrophage colony-stimulating factor (GM-CSF) is effective for impaired wound repair. Estrogen is
known to enhance wound repair. We examined if 17b-estradiol (E2) may in vitro enhance GM-CSF production in
human keratinocytes. E2 and membrane-impermeable bovine serum albumin-conjugated E2 increased GM-CSF
secretion, mRNA stability, and promoter activity. The element homologous to activator protein-1 (AP-1) on the
promoter was responsible for the activation. E2 enhanced transcriptional activity and DNA binding of AP-1. E2
transiently generated c-Fos protein, and shifted AP-1 composition from c-Jun homodimers to c-Fos/c-Jun het-
erodimers in keratinocytes. E2-induced enhancement of GM-CSF secretion, mRNA stability, and promoter activity
were not suppressed by estrogen receptor antagonist ICI 182,780, however, suppressed by conventional protein
kinase C inhibitor Go¨6976 and PD98059, an inhibitor of mitogen-activated protein kinase kinase (MEK). Go¨6976 and
PD98059 suppressed E2-induced c-Fos expression and enhancement of DNA-binding and transcriptional activity at
AP-1. E2 induced membrane translocation of protein kinase Ca, which was suppressed by phosphatidylinositol
(PI)-specific phospholipase C (PLC) inhibitor U73122. E2 stimulated the phosphorylation of extracellular signal-
regulated kinase (ERK), which was suppressed by PD98059, Go¨6976, and U73122. E2 transiently generated inositol
1,4,5-triphosphate in keratinocytes, which was suppressed by U73122 and guanine nucleotide-binding protein
inhibitor. These results suggest that E2 may enhance GM-CSF production via guanine nucleotide-binding protein-
coupled membrane receptors and signaling cascade of PI-specific PLC/protein kinase Ca/MEK/ERK.
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Granulocyte-macrophage colony-stimulating factor (GM-
CSF) accelerates skin wound healing (Kaplan et al, 1992;
Braunstein et al, 1994; Cantu¨rk et al, 1999; Jaschke et al,
1999). GM-CSF is mainly secreted by keratinocytes at the
wound edge, and potentiates the migration and proliferation
of endothelial cells and keratinocytes, which may promote
neovascularization and re-epithelialization (Mann et al,
2001). GM-CSF also promotes the transformation of fibro-
blasts into a-myofibroblasts (Jaschke et al, 1999), leading to
the formation of granulation tissues. GM-CSF also pro-
motes the survival and phagocytosis of macrophages
(Jones, 1993), which may eliminate bacteria or cell debris
and prevent infection.
Previous studies suggest that estrogen accelerates
wound repair by promoting the production of basic fibro-
blast growth factor (Rider et al, 1997) or transforming
growth factor-b, which induces fibroblasts to proliferate
and produce extracellular matrix, leading to the formation of
granulation tissues (Ashcroft et al, 1997). It is thus plausible
that estrogen may enhance GM-CSF production by kera-
tinocytes in the skin wound. Previous studies reported that
estrogen enhanced GM-CSF production in uterus (Robert-
son et al, 1996; Tamura et al, 1999; McGuire et al, 2002).
Precise mechanism for the effects, however, has not been
defined. Since GM-CSF production is regulated both at
transcriptional and post-transcriptional levels (Kanda and
Watanabe, in press), it should be identified which level of
GM-CSF production estrogen may potentiate.
It is known that estrogen manifests its effects by two
different mechanisms, genomic and non-genomic effects.
The former is that estrogen-bound nuclear estrogen recep-
tor (ER) a or b up- or downregulates gene expression by
binding to estrogen response element (ERE) of the target
genes or by interacting with other transcription factors like
nuclear factor-kB (NF-kB) (Beato, 1989; Kanda and Wata-
nabe, 2003a). On the other hand, in the latter case, estrogen
interacts with cell surface and rapidly induces intracellular
Abbreviations: AP-1, activator protein-1; DAG, 1,2-diacylglycerol;
E2, 17b-estradiol; E2-BSA, 17b-estradiol 6-(O-carboxymethyl)ox-
ime:bovine serum albumin; EMSA, electrophoretic mobility shift
assay; ER, estrogen receptor; ERE, estrogen response element;
ERK, extracellular signal-regulated kinase; GAPDH, glyceralde-
hyde-3-phosphate dehydrogenase; GM-CSF, granulocyte-ma-
crophage colony-stimulating factor; G-protein, guanine nucleotide-
binding protein; IP3, inositol 1,4,5-triphosphate; KBM, keratinocyte
basal medium; MEK, mitogen-activated protein kinase kinase; NF-
AT, nuclear factor of activated T cells; NF-kB, nuclear factor-kB; PI,
phosphatidylinositol; PLC, phospholipase C
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signals (Kelly and Levin, 2001); estrogen activates adenylate
cyclase (Aronica et al, 1994), phospholipase C (PLC) (Lie-
berherr et al, 1993), protein kinase C (PKC) (Marino et al,
2001a, b; Sylvia et al, 2001), or extracellular signal-regulated
kinase (ERK) (Migliaccio et al, 1996). Membrane targets of
estrogen include membrane-localized receptors structurally
related to classic nuclear ER, non-classic ER, and ligand- or
voltage-activated ion channels (Pappas et al, 1995; Razandi
et al, 1999; Benten et al, 2001; Nadal et al, 2001). Though
non-classic membrane ER has not been always success-
fully characterized, previous studies support the presence
of this type of receptor; some of the non-genomic effects
above are manifested by membrane-impermeable albumin
or peroxidase-conjugated estrogen, and are not sup-
pressed by classic ER antagonist, and the binding of pro-
tein-conjugated estrogen to the membrane is not impeded
by antibodies against classic ER (Aronica et al, 1994;
Watters et al, 1997; Nadal et al, 2000; Benten et al, 2001).
Non-classic membrane steroid receptor superfamily is also
indicated for androgen or progesterone (Benten et al, 1999;
Falkenstein et al, 1999). A putative membrane non-classic
progesterone receptor has been characterized and cloned
(Gerdes et al, 1998). As non-classic membrane ERs, several
guanine nucleotide-binding protein (G-protein)-coupled re-
ceptors have been identified such as an orphan receptor
GPR30 (Filardo et al, 2000) or the so-called g-adrenergic
receptor (Nadal et al, 2000).
In the previous studies, we reported that 17b-estradiol
(E2) in vitro enhanced the production of vascular endothelial
growth factor or nerve growth factor in human macrophag-
es (Kanda and Watanabe, 2002, 2003b). The results indicate
that E2 may promote angiogenesis and reinnervation in the
wound. In this study, we examined if E2 may in vitro en-
hance GM-CSF production in human keratinocytes, and
found stimulatory effects. We further examined the precise
mechanism for the effects focusing on E2-induced signaling
events.
Results
E2 and E2, 17b-estradiol 6-(O-carboxymethyl)oxime:
bovine serum albumin (E2-BSA) enhanced GM-CSF
secretion in keratinocytes E2 concentration-dependently
enhanced GM-CSF secretion in keratinocytes; the stimula-
tory effect of E2 was manifested at 109 M, maximized at
108 M, which increased the secretion 3.1-fold of controls
whereas at 106 M, the stimulatory effect of E2 was re-
duced and 105 M of E2 showed no significant effect
(Fig 1a). Such bell-shaped dose responses indicate mem-
brane receptor-mediated effects. This is also supported by
the phenomenon that membrane-impermeable E2-BSA en-
hanced GM-CSF secretion (Fig 1b) while BSA did not. The
viable cell number was not altered by E2 or E2-BSA when
harvesting the supernatants: mean  SEM 4.2  0.3,
4.3  0.4, or 4.1  0.4  104 per well in control, E2, or E2-
BSA-treated cells, respectively (n¼5). ER antagonist ICI
182,780 did not counteract the stimulatory effect of E2
(Fig 1b). ICI 182,780 was functional since it suppressed E2-
stimulated transcriptional activity through ERE in p4  ERE-
TATA-luc-transfected keratinocytes; luciferase ratio mean
 SEM 0.42  0.05, 3.61  0.40, or 0.43  0.04 in control,
E2-, or E2 plus ICI 182,780-treated cells, respectively (n¼5,
po0.05 in comparison between the latter two groups, by
ANOVA with Scheffe’s multiple comparison test). E2 stereo-
isomer 17a-estradiol did not enhance GM-CSF secretion.
These results suggest that membrane receptors different
from classic nuclear ER may mediate E2-induced enhance-
ment of GM-CSF secretion. Since 108 M of E2 was optimal
for GM-CSF induction, this concentration will be used in the
following experiments. We next examined if E2 may in-
crease steady-state GM-CSF mRNA level in keratinocytes.
E2 and E2-BSA increased GM-CSF mRNA levels At 3 h
of incubation, E2 or E2-BSA increased steady-state
GM-CSF mRNA level 2.8-fold or 2.9-fold of controls, re-
spectively (Fig 2), whereas 17a-estradiol and BSA were in-
effective. ICI 182,780 did not block the stimulatory effect of
E2. We then examined if E2 may enhance GM-CSF mRNA
stability.
E2 and E2-BSA stabilized GM-CSF mRNA Keratinocytes
were treated with actinomycin D after incubation with E2 for
Figure1
Concentration-dependent effects of E2 on GM-CSF secretion (a)
and the effects of ICI 182,780, or E2-BSA (b, c). (a) Keratinocytes
were incubated with indicated concentrations of E2 or 17a-estradiol for
24 h. The culture supernatants were assayed for GM-CSF. Values are
mean  SD of triplicate cultures. po0.05 versus control cultures, by
one-way ANOVA with Dunnett’s multiple comparison test. The data
shown are representative of five separate experiments. (b) Keratin-
ocytes were pre-incubated with 106 M ICI 182,780 (ICI) for 30 min, and
then incubated with E2, E2-BSA, or BSA (each 108 M) in the presence
of ICI for 24 h. Values are mean  SEM (n¼5). po0.05 versus control
cultures, by one-way ANOVA with Scheffe’s multiple comparison test.
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3 h, and the decay of GM-CSF mRNA was chased (Fig S1).
The estimated half-life of GM-CSF mRNA in E2- or E2-BSA-
treated cells was 1.93-fold or 1.87-fold of controls, respec-
tively, and significantly higher than controls (po0.05, by
one-way ANOVA with Scheffe’s multiple comparison test,
n¼4). ICI 182,780 did not suppress the E2-induced in-
crease of the half-life. These results indicate that E2 or E2-
BSA may stabilize GM-CSF mRNA via membrane receptors
different from classic ER.
E2 and E2-BSA enhanced GM-CSF promoter activity We
then examined if E2 may enhance GM-CSF transcription in
keratinocytes. Human GM-CSF gene contains cis-elements
homologous to NF-kB, activator protein-1 (AP-1), and nu-
clear factor of activated T cells (NF-AT) sites (Fig S2a), and
these may act as enhancer elements (Pastore et al, 1997).
E2 or E2-BSA increased wild-type GM-CSF promoter ac-
tivity 2.5-fold or 2.4-fold of controls, respectively (Fig S2b,
first three columns). Thus E2 and E2-BSA appeared to en-
hance GM-CSF transcription. ICI 182,780 did not block the
E2-induced increase of the activity (data not shown), indi-
cating that the effects of E2 may be independent of clas-
sical ER. The mutation of AP-1-like element reduced the
basal promoter activity and abrogated E2- or E2-BSA-in-
duced enhancement of the activity (Fig S2b, third three
columns). The mutation of NF-kB-like element reduced ba-
sal promoter activity, however, did not alter the fold induc-
tion by E2 or E2-BSA (Fig S2b, second three columns). The
mutation of NF-AT-like element did not affect basal, E2-, or
E2-BSA-induced promoter activities (Fig S2b, three col-
umns at the bottom), indicating that this element may be
dispensable for GM-CSF transcription. These results sug-
gest that AP-1-like element may be responsible for E2- or
E2-BSA-induced enhancement of GM-CSF promoter activ-
ity. We then analyzed if E2 or E2-BSA may enhance tran-
scriptional activity through AP-1-like element.
E2 and E2-BSA enhanced transcription from AP-1-like
element E2 or E2-BSA potently enhanced transcription
through AP-1-like element in keratinocytes (3.0-fold or 2.9-
fold of controls, respectively), while did not increase that
through NF-kB-like element (Fig S3). ICI 182,780 did not
block E2-induced enhancement of transcription through
AP-1-like element (data not shown).
E2 and E2-BSA induced c-Fos/c-Jun binding to AP-1
site by transient induction of c-Fos protein We then ex-
amined if E2 or E2-BSA may enhance DNA binding of tran-
scription factors at AP-1-like site on GM-CSF promoter. At
1 h of incubation, E2 and E2-BSA increased the amount of
DNA-protein complex with AP-1-containing probe (Fig 3a,
lanes 3 and 4). These results suggest that E2 or E2-BSA
may enhance transcription factor binding to AP-1-like site.
ICI 182,780 did not block the E2-induced enhancement of
DNA-binding activity (data not shown). In unstimulated ker-
atinocytes, anti-c-Jun did but anti-c-Fos antibody did not
supershift the complex (Fig 3a, lanes 5 and 6) while in E2-
stimulated keratinocytes (Fig 3a, lanes 7 and 8), both an-
tibodies supershifted the complex. Antibodies against the
other Fos family (FosB, Fra-1, Fra-2) or Jun family (JunB,
Figure 2
Effects of E2 on steady-state GM-CSF mRNA level. Keratinocytes
were pre-incubated with 106 M ICI 182,780 (ICI) for 30 min, and then
incubated with E2, E2-BSA, BSA, or 17a-estradiol (17a-E2) (each 108
M) in the presence of ICI. After 3 h, RNA was isolated, and RT-PCR was
performed. The intensity of the band for GM-CSF was corrected to that
for GAPDH. The lower graph shows corrected intensities relative to that
in controls (set as 1.0). The results shown are representative of five
separate experiments.
Figure3
Effects of E2 on DNA binding of AP-1 and on c-Fos or c-Jun protein
levels. (a) Keratinocytes were incubated with E2 or E2-BSA (each 108
M) or medium alone (Con) for 1 h. Nuclear extracts were prepared, and
incubated with AP-1 probe. In supershift assays, nuclear extracts were
pre-incubated with antibodies against c-Fos or c-Jun. The asterisks
indicate the supershifted complexes. (b) Keratinocytes were incubated
with 108 M E2. At indicated time-points, whole cell extracts were
isolated, and the expression of c-Fos or c-Jun was analyzed. The re-
sults shown are representative of five separate experiments.
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JunD) proteins did not supershift the complexes by nuclear
extracts from unstimulated or E2-stimulated keratinocytes
(data not shown). These results suggest that E2 may shift
the AP-1 composition from c-Jun homodimers to c-Fos/c-
Jun heterodimers. We then examined if E2 may increase c-
Fos or c-Jun protein levels in keratinocytes. E2 rapidly and
transiently induced c-Fos protein; c-Fos was constitutively
undetectable; however, after treatment with E2, c-Fos was
induced at 30 min, reduced at 1 h, and disappeared at 90
min (Fig 3b). c-Jun was constitutively detectable and was
not increased by E2. The results indicate that E2-induced
activation of AP-1 may be mainly attributable to the tran-
sient induction of c-Fos. E2-BSA transiently induced c-Fos
protein as well as E2 (data not shown).
PKCa and ERK were involved in E2-induced GM-CSF
production It is reported that E2 binding to the cell surface
activates a variety of signaling enzymes; adenylate cyclase,
PKC, or ERK (Migliaccio et al, 1996; Razandi et al, 1999).
We examined if specific inhibitors for these enzymes may
counteract the effects of E2. Go¨6976, an inhibitor of con-
ventional PKC, reduced both basal and E2-induced GM-
CSF secretion (Fig S4a), promoter activity (Fig S4b), and
mRNA stability (Fig S4c), indicating that conventional PKC
may be required for both basal and E2-induced GM-CSF
secretion, promoter activity, and mRNA stability. PD98059,
an inhibitor of mitogen-activated protein kinase kinase 1/2
(MEK1/2) which activates ERK, did not suppress basal GM-
CSF promoter activity (Fig S4b), however, reduced E2-in-
duced GM-CSF promoter activity to basal level (Fig S4b),
and partially suppressed basal and E2-induced GM-CSF
secretion (Fig S4a) and mRNA stability (Fig S4c). These re-
sults indicate that ERK may be involved in E2-induced en-
hancement of GM-CSF promoter activity, and partially
involved in basal and E2-induced GM-CSF secretion and
mRNA stability. On the other hand, a novel PKC inhibitor
rottlerin and adenylate cyclase inhibitor SQ22536 did not
affect basal or E2-induced GM-CSF secretion (Fig S4a),
promoter activity (Fig S4b), or mRNA stability (data not
shown). These results suggest the requirement of conven-
tional PKC and ERK for E2-induced enhancement of GM-
CSF production. These enzymes may also be involved in
basal GM-CSF production. The inhibitory effect of each in-
hibitor was similarly manifested in E2-BSA-stimulated ker-
atinocytes (data not shown).
E2-induced enhancement of AP-1 transcriptional activity
was blocked by Go¨6976 and PD98059 (Fig S5a) while that
was not altered by rottlerin or SQ22536 (data not shown).
Go¨6976 and PD98059 also suppressed the enhancement of
DNA binding at AP-1 site (Fig S5b) and c-Fos induction by
E2 (Fig S5c). These results suggest that conventional PKC
and ERK may be required for E2-induced c-Fos expression
and resultant activation of AP-1. Basal transcriptional ac-
tivity (Fig S5a) and DNA-binding activity at AP-1 (Fig S5b)
were reduced by Go¨6976, but not by PD98059, indicating
the involvement of conventional PKC in basal AP-1activity.
We then analyzed if E2 may stimulate conventional PKC
or ERK. To date, conventional PKCa, novel PKCd, e, Z, and
atypical PKCz have been detected in keratinocytes (Reyno-
lds et al, 1994), and thus PKCa may be the only conven-
tional PKC in keratinocytes. PKC stimulators like phorbol
12-myristate 13-acetate are reported to translocate PKC
from cytosol to membrane in keratinocytes (Reynolds et al,
1994). Previous studies also reported that E2 induced
membrane translocation of PKCa in female rat chondro-
cytes (Sylvia et al, 1998) or rat liver cells (Marino et al,
2001b). We thus analyzed if E2 may induce membrane
translocation of PKCa in keratinocytes. At 2 min of incuba-
tion, E2 or E2-BSA induced membrane translocation of
PKCa, which was suppressed by phosphatidylinositol-spe-
cific PLC (PI-PLC) inhibitor U73122 (Fig 4a). Thus E2-in-
duced translocation of PKCa may be dependent on PI-PLC
which hydrolyses PI-4,5-bisphosphate and generates in-
ositol 1,4,5-triphosphate (IP3) and 1,2-diacylglycerol (DAG),
the latter of which activates conventional and novel PKC. E2
or E2-BSA did not induce the membrane translocation of
PKCd, e, Z, or z (data not shown).
ERK is activated by MEK1/2 via dual phosphorylation on
threonine and tyrosine (Widmann et al, 1999). We thus
examined the phosphorylation status of ERK after E2
treatment. At five min, E2 and E2-BSA induced dual phos-
phorylation of ERK1/2 (Fig 4b), which was suppressed by
PD98059, Go¨6976, and U73122, indicating that E2-induced
activation of ERK may be dependent on conventional PKC
(possibly PKCa), MEK1/2, and PI-PLC. We then examined if
E2 may activate PI-PLC in keratinocytes by analyzing the
levels of IP3 and DAG. After E2 treatment, IP3 level in-
creased rapidly (within 15 s) with maximal stimulation at
Figure4
E2-induced membrane translocation of PKCa (a) and phosphor-
ylation of ERK1/2 (b). (a) Keratinocytes were pre-incubated with
U73122 (10 mM) for 30 min, and then incubated with E2, E2-BSA (each
108 M) for 2 min. Cytosolic and membrane fractions were isolated,
and the levels of PKCa in each fraction were analyzed. The results
shown in the figure are representative of five separate experiments. (b)
Keratinocytes were pre-incubated with 10 nM Go¨6976, 10 mM
PD98059, or 10 mM U73122 for 30 min, and then incubated with 108
M E2 or E2-BSA (each 108 M) in the presence of inhibitors for 5 min.
Whole cell extracts were subjected to SDS-PAGE followed by western
blot. The membranes were blotted with anti-phosphoERK antibody
(upper panel), then stripped and reprobed with anti-ERK antibody
(lower panel). The results shown are representative of five separate
experiments.
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30 s (2.13-fold of controls), then declined and returned to
basal level at 3 min (Fig S6a). On the other hand, E2 induced
a biphasic accumulation of DAG, peaking at 45 s and 5 min
(2.0-fold and 1.5-fold of controls, respectively) (Fig S6b). E2-
induced generation of IP3 was suppressed by U73122 (Fig
S6c), indicating that E2 may stimulate PI-PLC and thus
generate IP3. E2-BSA generated IP3 as well as E2 (Fig S6b),
indicating the membrane receptor-mediated effects. The
E2-induced accumulation of IP3 was blocked by G-protein
inhibitor GDPbS but not by ICI 182,780 or pertussis toxin.
These results suggest that E2 may activate PI-PLC via
pertussis toxin-resistant G-protein-coupled membrane re-
ceptors different from classic ER. We have recently found
that an orphan receptor GPR30 linked to adenylate cyclase
acts as a membrane non-classic ER in human keratinocytes
(Kanda and Watanabe, 2003d). On the other hand, Razandi
et al (1999) reported that membrane-localized classic ERa
or b may be linked to PLC in each receptor-transfected
Chinese hamster ovary cells. Since we previously detected
ERb and GPR30 mRNAs but not that of ERa in human ker-
atinocytes by RT-PCR (Kanda and Watanabe, 2003d), we
examined the involvement of ERb or GPR30 in E2-induced
activation of PI-PLC in keratinocytes, using anti-sense
oligonucleotides against these receptors. Neither ERb nor
GPR30 anti-sense suppressed E2-induced activation of PI-
PLC, PKCa, or ERK as well as E2-induced GM-CSF secre-
tion or transcription (Fig S7a–e). Similar results were ob-
tained by ERa anti-sense oligonucleotide (data not shown).
These anti-sense oligonucleotides are functional since ERb
or GPR30 anti-sense suppressed E2-induced transcription
through ERE or E2-induced cAMP signal in keratinocytes,
respectively (Fig S7f and g), and ERa anti-sense suppressed
E2-induced transcription through ERE in ERa-positive MCF-
7 cells (data not shown). Thus neither GPR30 nor classic
ERs may be involved in E2-induced activation of PI-PLC,
PKCa, ERK, and resultant GM-CSF production.
Discussion
E2 enhanced GM-CSF transcription via the activation of AP-
1, and also stabilized GM-CSF mRNA. PKCa and down-
stream kinase ERK are responsible for these effects. Pre-
vious studies also reported that PKC and/or ERK was
involved in GM-CSF production in human keratinocytes
(Uchi et al, 2003), or human bronchial epithelial cells (Re-
ibman et al, 2000). Our results indicate that E2 may bind to
membrane receptors and thus stimulate PI-PLC, which
generates DAG, an activator of PKCa. PKCa is known to
phosphorylate and activate c-Raf-1 (Scho¨nwasser et al,
1998), and the activated c-Raf-1 may further phosphorylate
and activate MEK1/2 catalyzing phosphorylation of ERK.
Thus the activation of putative membrane E2 receptors may
trigger the signaling cascade of PI-PLC/PKCa/c-Raf-1/
MEK1/2/ERK. E2 induced transient IP3 (30 s) and biphasic
DAG formation (45 s and 5 min), which was consistent with
previous results on E2-stimulated rat duodenal cells (Picotto
et al, 1999), and similarly occurs by the activation of G-
protein-coupled receptors for prostaglandin F2a, end-
othelin-1, or bradykinin (Fu et al, 1989; Fukami and Taken-
awa, 1989). The early peak of DAG was associated with that
of IP3 while the second peak of DAG was not, indicating that
the latter may originate from phospholipids other than PI, for
example, phosphatidylcholine. The first peak of DAG may
contribute to the activation of PKCa since the membrane
translocation of PKCa (2 min) preceded the second peak of
DAG (5 min). The stimulation of PI-PLC by E2 was sup-
pressed by GDPbS, but not by pertussis toxin, indicating
that pertussis toxin-insensitive G-proteins like Gq/11 may
couple putative membrane E2 receptors to PI-PLC in ker-
atinocytes. Putative membrane receptors may be different
from classic nuclear ERs since ICI 182,780 or ER anti-sense
oligonucleotides did not suppress the E2-induced stimula-
tion of PI-PLC. In rat chondrocytes (Sylvia et al, 1998, 2000,
2001) or breast carcinoma HCC38 cells (Boyan et al, 2003),
E2 or E2-BSA-induced activation of PI-PLC or PKC was
also resistant to ICI 182,780 or pertusssis toxin and sen-
sitive to GDPbS. It is thus indicated that structurally related
non-classic ER may be linked to PI-PLC in these cell types
and keratinocytes. As non-classic ERs, GPR30 may be
present in keratinocytes, however, may not be linked to PI-
PLC according to the results with anti-sense oligonucleo-
tides. Recently, the so-called g-adrenergic receptor linked
to guanylate cyclase was identified as one of non-classic
membrane ERs in pancreatic b cells (Nadal et al, 2000)
though its structure is not completely determined. Further
studies should examine if g-adrenergic receptors may be
present and linked to PI-PLC in keratinocytes. Alternatively,
a yet unidentified membrane receptor may confer E2-in-
duced activation of PI-PLC.
E2 appears to activate PI-PLC/PKC pathways in highly
divergent manners dependently on species and cell types;
E2 activated PI-PLC in rat osteoblasts via pertussis toxin-
sensitive G-protein-coupled membrane receptors (Lieberh-
err et al, 1993; Le Mellay et al, 1999). On the other hand, in
HepG2 cells or rat aortic smooth muscle cells, E2 activated
PI-PLC/PKCa pathway via membrane receptors structurally
related to nuclear ERa or b (Marino et al, 2001b; Incerpi et
al, 2003). The mechanism of ERK activation by E2 also dif-
fers with cell types and experimental conditions; E2 binds to
GPR30 in breast carcinoma MCF-7 cells and released he-
paran-bound-epidermal growth factor from cell surface,
which transactivates epidermal growth factor receptor ty-
rosine kinase and triggers Ras/Raf/MEK/ERK signaling cas-
cade (Filardo et al, 2000). In HEK293 cells, E2-bound ERa
activates insulin-like growth factor-1 receptor and triggers
the receptor-dependent Ras/Raf/MEK/ERK pathway (Kah-
lert et al, 2000). In human keratinocytes, however, E2-in-
duced activation of ERK may not involve GPR30 or classical
ERs according to the results with anti-sense oligonucleo-
tides.
Marino et al (2002) or Incerpi et al (2003) reported that
E2-induced activation of ERK and of PKCa occur in parallel,
though cross-talking each other, in HepG2 cells or rat aortic
smooth muscle cells. On the other hand, E2-induced acti-
vation of ERK was dependent on PKCa in human keratin-
ocytes. We have recently found that histamine activates
ERK dependently on PKCa in human keratinocytes (Kanda
and Watanabe, 2004). Thus PKCa may be tightly linked to
ERK in keratinocytes. Such linkage may be related to the
amounts, activation status, or subcellular localization of
PKCa, ERK1/2, and intermediate kinases, possibly c-Raf-1
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and MEK1/2. Among five PKC isoforms a, d, e, Z, and z in
keratinocytes, PKCa, d, e, and Z can be activated by DAG
generated by PI-PLC. Only PKCa, however, appeared to be
activated by E2. The results are consistent with those in rat
chondrocytes (Sylvia et al, 1998) or HCC38 cells (Boyan
et al, 2003). Possibly, PKCd, e, and Z may not respond to
E2-generated DAG due to their lower levels of expression or
tight compartmentalization in cytoplasm, or both.
E2 transiently induced c-Fos protein. The induced c-Fos
may heterodimerize with c-Jun and the heterodimers may
bind to AP-1-like site on GM-CSF promoter and drive tran-
scription. On the other hand, c-Jun homodimers bound to
AP-1-like site in unstimulated keratinocytes. It is reported
that DNA-binding and transcriptional activity of c-Fos/c-Jun
heterodimers are much higher than those of c-Jun ho-
modimers (Allegretto et al, 1990; Suzuki et al, 1991). Thus
E2 may enhance AP-1 activity by shifting its composition
from c-Jun homodimers to c-Fos/c-Jun heterodimers.
PKCa and downstream kinase ERK were required for the
c-Fos induction by E2. It is also reported that E2-BSA in-
duced c-Fos expression via ERK in neuroblastoma SK-N-
SH cells (Watters et al, 1997). c-fos promoter contains se-
rum response element where ternary complex factors like
Elk1 or SAP1 are binding (Janknecht et al, 1995; Soh et al,
1999). ERK-mediated phosphorylation of ternary complex
factor promotes its transcriptional activity (Marais et al,
1993). It is thus anticipated that the phosphorylation of ter-
nary complex factors by ERK may be involved in E2-in-
duced c-Fos expression. Go¨6976 suppressed constitutive
DNA-binding and transcriptional activity of AP-1, but
PD98059 did not. These results indicate that PKCa may
be responsible for constitutive AP-1 activity independent of
ERK. PKC is known to enhance DNA-binding activity of c-
Jun by dephosphorylating serine residues adjacent to the
DNA-binding domain (Boyle et al, 1991; Goode et al, 1992),
which may be an effect independent of ERK.
E2 stabilized GM-CSF mRNA dependently on PKCa and
ERK. 30 untranslated region of GM-CSF mRNA contains AU-
rich elements (ARE), which target mRNA for degradation by
ribonucleases (Shaw and Kamen, 1986). Stabilizer proteins
like YB-1 bind to ARE and block recognition by ribonuc-
leases (Capowski et al, 2001). Conversely, destabilizer pro-
teins like AUF1 bind to ARE and target ribonuclease
activities (Buzby et al, 1996). The activities of these ARE-
binding proteins are regulated by phosphorylation/de-
phosphorylation (Rajagopalan and Malter, 1994). E2 may
thus promote the binding of stabilizers or reduce that of
destabilizers, or both, by phosphorylation via PKCa, ERK, or
downstream kinases. Go¨6976 completely suppressed E2-
induced GM-CSF mRNA stabilization while the suppres-
sion by PD98059 was partial. This indicates that PKCa may
stabilize GM-CSF mRNA via ERK-dependent and -inde-
pendent mechanisms, the latter of which may be the phos-
phorylation of ARE-binding proteins by PKCa itself or
downstream kinases different from ERK. Further studies
should elucidate ARE-binding proteins targeted by PKCa or
ERK.
It is reported that GM-CSF is effective for impaired
wound healing associated with leprosy or venous insuffi-
ciency (Kaplan et al, 1992; Jaschke et al, 1999). Especial-
ly locally generated GM-CSF in the wound may act on
macrophages or neutrophils and normalize the impaired
phagocytotic activity associated with delayed wound repair
in aged or diabetic patients (Cantu¨rk et al, 1999; Swift et al,
2001). Our present results suggest that topical application
of E2 may accelerate in vivo wound healing via GM-CSF
induction. Skin wound healing requires a variety of growth
factors, and independent application of each growth factor
is not always effective (Jaschke et al, 1999). The combina-
tion of more than one growth factor may generate synergis-
tic effects on wound healing. E2 induces the production of
multiple growth factors in multiple cell types; the production
of nerve growth factor and vascular endothelial growth fac-
tor in macrophages (Kanda and Watanabe, 2002, 2003b),
transforming growth factor-b production in fibroblasts (Ash-
croft et al, 1997), and GM-CSF production in keratinocytes,
as shown in this study. The application of E2 to wound
may thus produce synergistic effects of these growth
factors for wound repair. GM-CSF is produced by many
cell types other than keratinocytes, such as macrophages,
Langerhans cells, dendritic cells, T cells, fibroblasts, or
endothelial cells (Mann et al, 2001), and these are also
the target of GM-CSF. Further studies should elucidate
if E2 may enhance GM-CSF production in these cell
types by mechanisms similar to or different from that in
keratinocytes.
Materials and Methods
Reagents E2-BSA, 17a-estradiol, and GDPbS were purchased
from Sigma (St Louis, MO). ICI 182,780 was from Wako Pure
Chemical Industries (Osaka, Japan). U73122, PD98059, Go¨6976,
rottlerin, and SQ22536 were obtained from Calbiochem (La Jolla,
CA). Antibodies used in electrophoretic mobility shift assay (EMSA)
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Culture of keratinocytes Human neonatal foreskin keratinocytes
were cultured in serum-free KGM medium (Clonetics, Walkersville,
MD) consisting of basal medium MCDB153 supplemented with 0.5
mg per mL hydrocortisone, 5 ng per mL epidermal growth factor, 5
mg per mL insulin, and 0.5% bovine pituitary extract. The cells in
third passage were used.
GM-CSF secretion Keratinocytes (4  104 per well) were seeded
in triplicate into 24-well plates in 0.4 mL KGM, adhered overnight,
then the medium was changed to phenol red-free keratinocyte
basal medium (KBM) depleted of growth supplements, and incu-
bated for 24 h. The medium was removed and the cells were in-
cubated with E2 or E2-BSA in KBM for 24 h. The supernatants
were assayed for GM-CSF by ELISA (Biosource, Camarillo, CA).
RT-PCR Keratinocytes were incubated as above for 3 h, then
total cellular RNA was extracted using TRIzol reagent (Invitrogen,
Rockville, MD), and was reverse-transcribed to produce cDNA as
described (Tjandrawinata et al, 1997). The cDNA was thermocy-
cled for PCR as described (Kanda and Watanabe, in press), using
primers listed in Table S1 (Sorg et al, 1991; Kanda and Watanabe,
2002). PCR was performed by 951C for 3 min, 25 cycles of 951C for
30s, 581C for 30s, and 721C for 30 s, and 721C for 3 min. The PCR
products for GM-CSF (expected size 165 bp) and glyceralde-
hyde-3-phosphate dehydrogenase (glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), 566 bp) were analyzed by elect-
rophoresis on 2.5% agarose gels and stained with ethidium bro-
mide. Densitometric analysis of the bands was performed by NIH
Image Software. The mRNA level of GM-CSF was normalized to
that of GAPDH.
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mRNA stability analysis Keratinocytes were incubated with KBM
alone or with E2 or E2-BSA for 3 h. RNA synthesis was blocked by
actinomycin D (5 mg per mL), and RNA was isolated 0, 30, 60, and
90 min later. RT-PCR was performed as described above, and the
decay of mRNA was determined from band density ratios of GM-
CSF/GAPDH.
Plasmids and transfections The firefly luciferase reporter plasm-
ids driven by human GM-CSF promoter (620/þ 37 bp relative to
the transcriptional start site) were constructed by PCR and inser-
tion into pGL3 basic vector (Promega) as described (Himes et al,
1993), and denoted as pGM-CSF luc. Site-specific mutation of the
promoter was created by multiple rounds of PCR using primers
with altered bases as described (Himes et al, 1993; Pastore et al,
1997). p4  NF-kB-TATA-luc, p4  AP-1-TATA-luc, or p4  ERE-
TATA-luc were constructed by inserting four copies of NF-kB, AP-1
from human GM-CSF promoter, or ERE from vitellogenin A2 pro-
moter (Table S1) in front of TATA box upstream of firefly luciferase
reporter as described (Kanda and Watanabe, 2003c). Transient
transfections were performed with Fugene 6 (Roche, Indianapolis,
IN) as described (Effinova and Eckert, 2000). Keratinocytes were
plated in 35-mm dishes and grown to about 60% confluence.
Fugene 6 pre-mixed with KGM was mixed with pGM-CSF luc or
p4  NF-kB, AP-1, or ERE-TATA-luc and herpes simplex virus thy-
midine kinase promoter-linked renilla luciferase vector (pRL-TK),
and incubated at room temperature for 15 min. The mixture was
added to keratinocytes in KGM. After 24 h, the transfected cells
were washed and incubated in phenol red-free KBM for 18 h, then
treated with E2 in KBM. After 6 h, cell extracts were prepared and
firefly and renilla luciferase activities were quantified by dual lucif-
erase assay system (Promega). The results in each transfection
were expressed as ratios of firefly:renilla luciferase activities.
EMSA EMSA was performed as described (Jenkins et al, 1995).
The probes used were 32P-labelled annealed double-stranded
DNA containing AP-1 from human GM-CSF promoter (Table S1).
Nuclear protein extracts were incubated at room temperature for 5
min with a mixture containing 6 mM HEPES (pH 7.9), 0.4 mM
EDTA, 125 mM KCl, 10% glycerol, 0.05 mg per mL poly dI-dC, 1 mM
DTT, 2.5 mM sodium pyrophosphate, 1 mM b-glycerophosphate, 1
mM Na3VO4, 10 mM NaF, 50 mg per mL aprotinin, 50 mg per mL
leupeptin. A labeled probe was added and the reactions were in-
cubated for another 20 min. In antibody supershift experiments,
the nuclear extracts were pre-incubated with various antibodies for
30 min before the addition of probe. Reactions were fractionated
on a non-denaturing 5% polyacrylamide gel, and visualized with
phosphorimager (Molecular Dynamics, Sunnyvale, CA).
Western blot analysis Keratinocytes were incubated with E2 for
indicated periods. The cells were lysed with lysis buffer (50 mM
HEPES (pH 7.5), 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1.5
mM MgCl2, 100 mM NaF, 100 mM sodium orthovanadate, and 1
mM EGTA (pH 7.7)) followed by centrifugation for 20 min at
14,000  g at 41C. The supernatant proteins were subjected to
SDS-PAGE, and transferred to a nitrocellulose membrane. The
membrane was blocked, and incubated with anti-human c-Fos or
c-Jun antibodies (Santa Cruz Biotechnology), followed by per-
oxidase-conjugated secondary antibodies (Bio-Rad, Hercules,
CA). The blots were developed with an enhanced chemilumines-
cence kit (Amersham, Arlington Heights, IL).
To detect the subcellular localization of PKC isoforms, cytosolic
and membrane fractions were obtained. Nuclei and debris were
removed from whole cell lysates by centrifugation (500  g, 5 min),
and this post-nuclear fraction was centrifuged (105,000  g, 90
min). The supernatant was saved as cytosolic fraction. The pellet
was homogenized in the same buffer, except for containing 0.1%
Triton X-100. The samples were mixed continuously for 1 h at 41C,
and then centrifuged as described above. This supernatant was
saved as membrane fraction. The proteins of cytosolic or mem-
brane fractions were subjected to SDS-PAGE, transferred as
above, and the blots were incubated with antibodies against PKC
isoforms (Santa Cruz Biotechnology), followed by secondary an-
tibodies, and developed as above.
Measurement of IP3 IP3 and DAG were measured as described
(Fukami and Takenawa, 1989). Keratinocytes were seeded into
6-cm dishes, adhered overnight, then starved in phenol red-free
KBM for 24 h. The medium was removed and the cells were
incubated with E2 or E2-BSA for indicated periods at 371C, and
incubations were terminated by aspirating the medium, washing
with phosphate-buffered saline, and adding trichloroacetic acid
and then distilled water. Both fractions were collected in a tube.
The extracts were centrifuged at 5000  g for 10 min, and the re-
sulting supernatant was washed with diethyl ether saturated with
distilled water to remove trichloroacetic acid. The pH of the supe-
rnatant was adjusted to 7.4 with 10% NaHCO3, and aliquots of the
supernatant were used for IP3 using radioimmunoassay (Amersham).
Measurement of DAG Keratinocytes were incubated as above,
and the reactions were terminated by aspirating the medium,
washing with phosphate-buffered saline, and adding ice-cold
methanol. The cells were scraped off, and were washed with
chloroform/methanol (1:2, vol/vol). Lipids were extracted with
chloroform and washed with 1 M KCl. The extracts were analy-
zed for DAG using DAG assay kit (Amersham).
Treatment with anti-sense oligodeoxynucleotides Anti-sense
oligonucleotides (Table S1) were synthesized as described (Lau et
al, 2000), and were transfected into keratinocytes as described
(Kanda and Watanabe, 2003d). Briefly, keratinocytes were trans-
fected finally with 0.2 mM of the indicated oligonucleotides pre-
mixed with Fugene6 in phenol red-free KBM for 4 h. The medium
was aspirated and fresh medium containing E2 was added.
Measurement of cAMP amount Intracellular cAMP levels of ker-
atinocytes were analyzed as described (Kanda and Watanabe,
2003d), using ELISA (Amersham).
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The following material is available from http://www.blackwellpublishing.
com/products/journals/suppmat/JID/JID23231/JID23231sm.htm
Figure S1
Effects of E2 on GM-CSF mRNA stability. Keratinocytes were pre-
incubated with 106 M ICI 182,780 (ICI) for 30 min, and then incubated
with E2 or E2-BSA (each 108 M) in the presence of ICI for another 3 h.
Actinomycin D (5 mg per mL) was added and RNA was isolated 0, 30,
60, and 90 min later, and RT-PCR was performed. The ratio of GM-CSF/
GAPDH mRNA band density was normalized to that at 0 min (set as
100%). The data are mean  SEM of four separate experiments. Half-
life of GM-CSF mRNA is noted for each condition.
Figure S2
Effects of E2 on the activities of wild-type or mutated GM-CSF
promoters. (a) Schematic representation of human GM-CSF promoter.
The locations of cis-elements are shown with their sequences, and
substituted bases for mutation are indicated. The nucleotide positions
are relative to the transcriptional start site. (b) Keratinocytes were tran-
siently transfected with wild-type (WT) or mutated pGM-CSF luc to-
gether with pRL-TK. The cells were treated with E2 or E2-BSA (each
108 M). After 6 h, firefly and renilla luciferase activities were analyzed.
The data shown as firefly: renilla luciferase ratios are mean  SEM of
four separate experiments. Values at right indicate the fold induction
versus basal promoter activity. po0.05 versus control values, by one-
way ANOVA with Scheffe’s multiple comparison test.
Figure S3
Effects of E2 on AP-1 or NF-jB transcriptional activities. Keratin-
ocytes were transiently transfected with p4  AP-1 or NF-kB-TATA-luc
or enhancerless pTATA-luc, together with pRL-TK. The cells were
treated with E2 or E2-BSA (each 108 M). After 6 h, luciferase activities
were analyzed. The results represent mean  SEM of four separate
experiments. Values at right indicate the fold induction versus basal
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Figure S4
Inhibition by several signal inhibitors on basal or E2-induced GM-
CSF secretion (a), promoter activity (b), and mRNA stability (c). (a)
Keratinocytes were pre-incubated with 10 nM Go¨6976, 10 mM rottlerin,
10 mM PD98059, 200 mM SQ22536 for 30 min, and then incubated with
108 M E2 in the presence of inhibitors. Culture supernatants were
harvested after 24 h. (b) Keratinocytes were transiently transfected with
pGM-CSF luc together with pRL-TK, pre-incubated with inhibitors, and
incubated with E2 as above. After 6 h, luciferase activities were analy-
zed. (c) Keratinocytes were pre-incubated with inhibitors and then in-
cubated with E2 as above. After 3 h, actinomycin D (5 mg per mL) was
added, and GM-CSF mRNA decay was chased 0, 30, 60, and 90 min
later. The data are mean  SEM of five separate experiments. po0.05
versus control values, wpo0.05 versus values with E2 alone, by one-
way ANOVA with Scheffe’s multiple comparison test. In (c), half-life of
GM-CSF mRNA is noted for each condition.
Figure S5
Inhibition by PKCa or ERK inhibitors on E2-induced transcriptional
activity (a) and DNA binding (b) at AP-1, and c-Fos expression (c).
(a) Keratinocytes were transfected with p4  AP-1-TATA-luc together
with pRL-TK, pre-incubated with 10 nM Go¨6976, 10 mM PD98059 for
30 min, and then incubated with E2 108 M in the presence of inhib-
itors. After 6 h, luciferase activities were analyzed. The data are mean 
SEM of five separate experiments. po0.05 versus control values,
wpo0.05 versus values with E2 alone, by one-way ANOVA with Scheffe’s
multiple comparison test. (b, c) Keratinocytes were pre-incubated with
inhibitors, and incubated with E2 as above. EMSA was performed at 1 h
(b) while c-Fos protein level was analyzed at 30 min (c). The results
shown in the figure are representative of five separate experiments.
Figure S6
Kinetics of E2-induced accumulation of IP3 (a) and DAG (b), and the
inhibition by GDPbS on E2-induced IP3 generation (c). (a, b) Kera-
tinocytes were incubated with E2 108 M for the indicated periods. The
levels of IP3 or DAG were measured as described in Materials and
Methods. The data are mean  SEM of four separate experiments. (c)
Keratinocytes were pre-incubated with 100 ng per mL pertussis toxin
(PTX) for 16 h, or 10 mM U73122, 106 M ICI 182780 (ICI), 10 mM
GDPbS for 30 min, and then incubated with E2, E2-BSA, or BSA (each
108 M) in the presence of inhibitors for 30 s. The level of IP3 was
measured. The data are mean  SEM of five separate experiments.
po0.05 versus control values, wpo0.05 versus values with E2 alone,
by one-way ANOVA with Scheffe’s multiple comparison test.
Figure S7
Neither ERb nor GPR30 anti-sense oligonucleotide suppressed E2-
induced IP3 generation (c), PKCa membrane translocation (a), ERK
phosphorylation (b), GM-CSF promoter activation (d), and secre-
tion (e). (a–c and e) Keratinocytes transfected with anti-sense (AS) or
control scrambled oligonucleotides (ODN) were incubated with 108 M
E2. IP3 generation (c), membrane translocation of PKCa (a), ERK phos-
phorylation (b), intracellular cAMP level (g), or GM-CSF secretion (e)
was evaluated at 30 s, 2 min, 5 min, 30 min, and 24 h, respectively. In (d,
f), keratinocytes were transfected with pGM-CSF luc (d) or p4  ERE-
TATA luc (f) together with pRL-TK and anti-sense oligonucleotides, and
treated with E2 for 6 h, then luciferase assay was performed. In (c–g),
values are mean  SEM of five separate experiments. po0.05 versus
values with medium alone, wpo0.05 versus values with E2 alone, by
one-way ANOVA with Scheffe’s multiple comparison test. The results
shown in (a, b) are representative of five separate experiments.
activity. po0.05 versus control values, by one-way ANOVA with
Scheffe’s multiple comparison test.
Table S1. Sequences of RT=PCR primers, response elements for
luciferase vectors, EMSA probe, and antisense oligonucleotides
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